These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8499810)

  • 1. The selected list.
    Bateman DN
    BMJ; 1993 May; 306(6886):1141-2. PubMed ID: 8499810
    [No Abstract]   [Full Text] [Related]  

  • 2. Controlling the NHS drugs budget. Combine old "proplist" with BNF.
    Marshall IW
    BMJ; 1994 Sep; 309(6956):738. PubMed ID: 7950535
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicines management. Fit to bust.
    Calvert R
    Health Serv J; 2002 Oct; 112(5826):24-5. PubMed ID: 12397667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health economics. Perfect combination.
    Youle M; Weston R; Trueman P; Swaden L; Leake H
    Health Serv J; 1999 Oct; 109(5675):26-7. PubMed ID: 10662318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discussing the limited list.
    Lancet; 1985 Feb; 1(8425):411-2. PubMed ID: 2857468
    [No Abstract]   [Full Text] [Related]  

  • 6. Restricted NHS drug list and gastroenterology.
    Whorwell PJ; Miller JP
    Lancet; 1985 Jan; 1(8419):52. PubMed ID: 2856979
    [No Abstract]   [Full Text] [Related]  

  • 7. The limited list: effects in general practice.
    Drug Ther Bull; 1987 Mar; 25(6):21-4. PubMed ID: 3569047
    [No Abstract]   [Full Text] [Related]  

  • 8. The status of modeled claims.
    Langley PC
    J Med Econ; 2015; 18(12):991-2. PubMed ID: 26549706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of medicines. Kicking the habit.
    Shepherd M; Hanson L
    Health Serv J; 1997 Aug; 107(5568):28-9. PubMed ID: 10173459
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug formularies--good or evil? A view using prescribing analyses and cost trends data.
    Chapman S
    Cardiology; 1994; 85 Suppl 1():46-53. PubMed ID: 7743535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limiting the drugs list. Behavioural treatment not drugs for chronic pain.
    Pither CE; Ralphs J
    BMJ; 1993 Jun; 306(6893):1687-8. PubMed ID: 8324453
    [No Abstract]   [Full Text] [Related]  

  • 12. Costs of some drugs will be displayed on packs to try to reduce waste and improve adherence.
    Torjesen I
    BMJ; 2015 Jul; 351():h3637. PubMed ID: 26139387
    [No Abstract]   [Full Text] [Related]  

  • 13. Trusts will not be able to exclude drugs approved by NICE from formularies, says Lansley.
    Dyer C
    BMJ; 2012 Jan; 344():e366. PubMed ID: 22246273
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug costs. Compound interests.
    Stewart A
    Health Serv J; 1994 Dec; 104(5431):30-1. PubMed ID: 10139796
    [No Abstract]   [Full Text] [Related]  

  • 15. Interpretation and management of PACT (prescribing analysis and cost) data on formularies.
    de Berker D
    BMJ; 1990 Oct; 301(6755):817-8. PubMed ID: 2224280
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes to the regulation of drug prices in the UK.
    Collier J
    BMJ; 2008 Dec; 337():a2735. PubMed ID: 19114449
    [No Abstract]   [Full Text] [Related]  

  • 17. Transferring the costs of expensive treatments. Guidelines may clarify responsibility for prescribing.
    Young M; Colwill S; Spiby J
    BMJ; 1995 May; 310(6990):1335. PubMed ID: 7773077
    [No Abstract]   [Full Text] [Related]  

  • 18. The pharmaceutical price regulation scheme.
    Collier J
    BMJ; 2007 Mar; 334(7591):435-6. PubMed ID: 17332539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The wrong prescription for drug prices.
    Birtwistle M
    Health Serv J; 2014 Apr; 124(6395):18. PubMed ID: 25029784
    [No Abstract]   [Full Text] [Related]  

  • 20. Prescription charges: are they worth it?
    Appleby J
    BMJ; 2014 Jun; 348():g3944. PubMed ID: 24943227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.